cirm.ca.gov

Clinical Trial Stage Projects

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate stem cell treatments to patients with unmet medical needs. With our Clinical Stage Programs, we intend to speed up ...
cirm.ca.gov

Digging Deeper Into Cardiovascular Plasma Proteomics: Opportunities and Limitations of Current Platforms.

Pich Chhay, Owen Tang, Lizhuo Ai, Stuart J Cordwell, Michael P Gray, Jean Y H Yang, Jennifer E Van Eyk, Peter J Psaltis, Gemma A Figtree Even though doctors have gotten much better at managing classic ...
cirm.ca.gov

¡Qué dolor de espalda!: etiología, diagnóstico y futuras líneas de tratamiento para el dolor lumbar discogénico.

Chronic lower back pain is a massive global issue that is usually linked to the wearing down of the shock-absorbing discs in our spine. For a long time, doctors focused mostly on the physical damage ...
cirm.ca.gov

What a pain in the back: etiology, diagnosis and future treatment directions for discogenic low back pain.

Giselle Kaneda, Lea Zila, Jacob T Wechsler, Karim Shafi, Karandeep Cheema, Hyun Bae, Sang D Kim, Alexander Tuchman, Debiao Li, Dmitriy Sheyn Chronic lower back pain is a massive global issue that is ...
cirm.ca.gov

Stem cell research in space: Advancing regenerative medicine beyond Earth.

Sending stem cells into space turns out to be an incredible way to study human biology because the lack of gravity profoundly changes how these cells grow, divide, and transform. By launching ...
cirm.ca.gov

CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials

South San Francisco, CA, December 11, 2025 – The California Institute for Regenerative Medicine (CIRM) governing board today approved funding of over $160 million for 16 new research awards to develop ...
cirm.ca.gov

CIRM approves new $100 million plan to accelerate genetic therapies for patients with rare diseases

South San Francisco, Calif., January 30, 2026 – The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, which sets aside ...
cirm.ca.gov

CIRM approves over $111 million to support discovery and clinical research

The awards approved by the board support three clinical trial (CLIN2) grant applications with a combined approved total of $31M in financial support from CIRM. These grants fund clinical trials for ...
cirm.ca.gov

CIRM invests more than $42 million in translational-stage research

South San Francisco, CA, Oct. 27, 2023– The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $42.1 million to fund ...
cirm.ca.gov

CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities

South San Francisco, Calif., October 30, 2025 – The California Institute for Regenerative Medicine (CIRM) has approved awarding $27 million through three grants across the state to create a network of ...
cirm.ca.gov

Kevin Xu Joins Board of California’s Stem Cell Agency

South San Francisco, CA – The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, is pleased to announce the appointment of Kevin ...
cirm.ca.gov

Disease Team Therapy Development – Research

The Disease Team Therapy Development Award initiative is an expansion of our original Disease Team Award Initiative. The purpose of the CIRM Disease Team Therapy Development Awards is to advance ...